New Study Derives Prostate Cancer Heat Map & Analysis Along with Clinical Benchmarks for Therapies during 2016-2022 No of Pages – 21 Publishing Date - September, 2016 Browse detailed TOC, Tables, Figures, and Charts in Global Serial Device Server Consumption 2016 Market Research Report at:
http://www.marketresearchhub.com/report/prostate-cancer-heat-map-and-analysis-report.html Market Research Hub has recently added a new report to its repository titled as “Prostate Cancer- Heat Map and Analysis�. This study provides details on the current clinical landscape by considering the treatment options for this disease. Also, currently approved therapies for prostate cancer and their clinical characteristics in terms of specific safety and efficiency parameters are also mentioned. Moreover, marketed products and pipeline products are highlighted in details.
Furthermore, a detailed analysis of the clinical benchmarks set by the current market landscape and the expected changes to these benchmarks along with the treatment algorithm for the latestage pipeline is clearly provided. According to the Prostate Cancer Market Report, the PC market consists of therapies for both hormone-sensitive and castration-resistant procedures of the disease. But, the options available for the two forms are particularly different with hormonal therapies used in the hormone-sensitive stage, whereas chemotherapy or targeted therapies used in the castration-resistant stage. Between them, hormonal therapies are widely used across multiple stages of the hormone-sensitive disease and the goal is to stop cancer growth enthused by testosterone.
Table of Contents 1 Table of Contents 1 Table of Contents 2 2 Introduction 3 2.1 Report Guidance 4 3 Marketed Products 5 3.1 Hormone-Sensitive Localized or Locally Advanced Prostate Cancer 5 3.2 Hormone-Sensitive Advanced or Metastatic Prostate Cancer 5 3.3 Metastatic Castration-Resistant Prostate Cancer 7 3.3.1 mCRPC - Normal Progression 7 3.3.2 mCRPC with Rapid Progression or Symptomatic mCRPC 9 3.3.3 Docetaxel-Resistant/Refractory mCRPC 9 4 Pipeline Products 11 4.1 Changes to Hormone-Sensitive Localized Disease, 2016-2022 11 4.2 Changes to Hormone-Sensitive Metastatic Prostate Cancer, 2016-2022 12 4.3 Changes to Metastatic Castration-Resistant Prostate Cancer, 2016-2022 13 4.3.1 mCRPC - First Line 13 4.3.2 mCRPC - Second Line 15
Request for Free Sample Report
5 Appendix 17 5.1 Abbreviations 17 5.2 References 17 5.3 Research Methodology 20 5.4 Contact Us 21 5.5 Disclaimer 21
Report Details – Date of Publishing – September, 2016 No of Pages – 21 Single User License – $2000 Multiple User License – $4000
Buy Report Now! About Market Research HUB : Market Research HUB is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Contact– 90 State Street, Albany, NY 12207, United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : mailto:sales@marketresearchhub.com Website : http://www.marketresearchhub.com/